The American Cancer Society (ACS) in partnership with Canary Foundation has a postdoctoral fellowship program focused on studies towards development of strategies for the early detection of cancer. This program is crucial to ensuring that both the best and brightest researchers are drawn to early detection research and that institutions conducting early detection research will have the talented personnel they need.
ACS is dedicated to eliminating cancer as a major health problem by preventing cancer, saving lives, and diminishing suffering from cancer, through research, education, advocacy and service. Its activities include providing grants to researchers, running public health advertising campaigns, and organizing projects.
The Public Library of Science (PLoS) has teamed up with Canary Foundation to create an online hub to aggregate information on early detection of cancer called The Canary Journal.
PLoS is a nonprofit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource.
PLoS goals are to:
- Open the doors to the world's library of scientific knowledge by giving any scientist, physician, patient, or student - anywhere in the world - unlimited access to the latest scientific research.
- Facilitate research, informed medical practice, and education by making it possible to freely search the full text of every published article to locate specific ideas, methods, experimental results, and observations.
- Enable scientists, librarians, publishers, and entrepreneurs to develop innovative ways to explore and use the world's treasury of scientific ideas and discoveries.
PLoS publishes scientific papers in six different subject-focused journals as well as in PLoS ONE an online, high-volume, swift, efficient, and economical system for the publication of peer-reviewed research in all areas of science and medicine, with innovative user tools for post-publication commenting, rating, and discussion.
The goal of the International Cancer Biomarker Consortium (ICBC) is to advance medical research and improve patient outcomes by discovering biomarkers (indicators) for multiple types of cancer. The consortium is focusing on biomarkers for the assessment of disease risk, early detection of disease, therapeutic prognosis, and response to treatment as well as disease recurrence. Canary sponsors the annual ICBC symposium attended by scientists from around the world.
Through a large-scale effort similar to the Human Genome Project, the consortium aims to make significant progress in the discovery of biomarkers by facilitating highly coordinated research and by leveraging resources and expertise from around the world to overcome the current obstacles in biomarker research. Each international team will choose a cancer site(s) for study, function independently, and secure its own funding. At the same time, the ICBC will provide a structure for international teams to work together on global issues such as adoption of data standards and the sharing data as well as on scientific details such as the logistics of tissue sample sharing and investigation of mouse models of cancer. The Fred Hutchinson Cancer Research Center will coordinate the research endeavor by providing bioinformatics resources including software and tools for data management including storage, organization, analysis, and sharing.
Under the leadership of Dr. Lee Hartwell, President and Director of Fred Hutchinson Cancer Research Center, the ICBC is pioneering a new model for biomarker discovery and developing technologies and methodologies to make it possible. The Consortium has a Steering Committee that includes prominent leaders in proteomics.
Copyright © 2010 Canary Foundation. All rights reserved.